Merck Abandons New Hepatitis C Drugs
Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and determining there is already an abundance of treatments, including its own Zepatier drug.
from Biotech News
Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and determining there is already an abundance of treatments, including its own Zepatier drug.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments